The enteral feeding tube market was valued at USD 1.14 billion in 2025 and is projected to surpass USD 1.69 billion by 2033, indicating a robust CAGR of 5.1%.

Enteral feeding tubes are medical devices that provide nutrition directly into the gastrointestinal tract for individuals who are unable to eat normally. It is placed through the nose, mouth, or abdomen wall, according with the length and type of feeding needed. Common forms include nasogastric (NG), gastrostomy (G-tube), and jejunostomy (J-tube). Enteral feeding tubes are typically used to treat patients with swallowing problems, neurological issues, or severe illnesses.
The demand for enteral feeding is predicted to increase as populations age and chronic diseases become more prevalent. Technological advances will enhance tube materials, delivery systems, and patient comfort. Enteral feeding will play a significant part in individualized nutrition and home-based care.
Growing Geriatric and Active Population Fuels the Enteral Feeding Tube Market Value
The enteral feeding tube market is expanding rapidly, driven by the growing elderly population and the rising frequency of chronic diseases. According to the World Health Organization (WHO), by 2030, one in every six persons worldwide would be 60 or older. The population of this age group is expected to increase from 1 billion in 2020 to 1.4 billion by that year. By 2050, the number of persons aged 60 and up is predicted to treble, to 2.1 billion. Additionally, the population aged 80 years or older is expected to treble between 2020 and 2050, reaching 426 million.
As people age, they become more vulnerable to illnesses like stroke, dementia, and cancer, which frequently affect their capacity to ingest meals orally. Enteral feeding tubes provide an important option by administering nutrients directly to the gastrointestinal tract. Furthermore, advances in medical technology and a move toward home-based care are making enteral feeding more accessible and user-friendly, which is driving market growth.
Expansion of Telemedicine and Remote Physiotherapy Solutions Offer Significant Enteral Feeding Tube Market Opportunity
The fast growth of telemedicine and remote physiotherapy solutions is creating substantial prospects in the enteral feeding tube market. For example, according to Telehealth.HHS.gov, Medicare enrollees can get telehealth services for non-behavioral and non-mental health care from home until September 30, 2025. Furthermore, all qualifying Medicare providers are authorized to provide telehealth services until this date, providing continuing access to remote treatment.
These digital healthcare innovations allow for better patient monitoring and control at home, increasing the demand for dependable enteral feeding systems. As telehealth evolves, the market for enteral feeding tubes is likely to increase significantly, driven by convenience and better patient outcomes.
The global market for enteral feeding tube has been segmented into product type, patient, application, end-users, and region.
In terms of enteral feeding tube market analysis, North America leads due to its advanced healthcare infrastructure, widespread acceptance of breakthrough medical technologies, and the strong presence of leading industry competitors. Furthermore, widespread awareness and reimbursement assistance contribute to market growth.

The enteral feeding tube market in Asia-Pacific is rising rapidly, owing to improved healthcare facilities, increased knowledge of enteral nutrition, and an expanding patient base. The rising frequency of chronic diseases and malnutrition, together with increased government measures to promote healthcare access, fuel demand.
The key players operating in the enteral feeding tube market report include Applied Medical Technology, Inc, CONMED Corporation, C.R. Bard, Inc, Medline Industries, Inc., Danone S.A., B. Braun Melsungen AG, Becton, Dickinson and Company, Avanos Medical, Inc., Abbott Laboratories, MOOG Inc., Cardinal Health, Cook Medical, Boston Scientific Corporation, Fresenius Kabi AG, and Vygon.
| Parameter | Details |
| Size in 2025 | USD 1.14 Billion |
| Forecast by 2033 | USD 1.69 Billion |
| CAGR During 2025 - 2033 | 5.1% |
| Largest Region Size (2025) | North America - USD 392.4 Million |
| Fastest Growing Region (% CAGR) | Asia-Pacific– 5.8% |
| Key Players Covered | Applied Medical Technology, Inc, CONMED Corporation, C.R. Bard, Inc, Medline Industries, Inc., Danone S.A., B. Braun Melsungen AG, Becton, Dickinson and Company, Avanos Medical, Inc., Abbott Laboratories, MOOG Inc., Cardinal Health, Cook Medical, Boston Scientific Corporation, Fresenius Kabi AG, and Vygon. |
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
India: +91 8983225533
E-mail: [email protected]